Baylor College of Medicine: Preoperative Immunotherapy For Mesothelioma Shows Favorable Outcomes
December 14, 2022
December 14, 2022
HOUSTON, Texas, Dec. 14 (TNSjou) -- The Baylor College of Medicine issued the following news:
In a study published recently in the journal Clinical Cancer Research, researchers at Baylor College of Medicine found that treating patients who have resectable malignant pleural mesothelioma, meaning that their tumor can be removed with surgery, with immunotherapy ahead of surgery resulted in favorable clinical outcomes. The study lays the groundwork for neoadjuvant immunotherapy in mesot . . .
In a study published recently in the journal Clinical Cancer Research, researchers at Baylor College of Medicine found that treating patients who have resectable malignant pleural mesothelioma, meaning that their tumor can be removed with surgery, with immunotherapy ahead of surgery resulted in favorable clinical outcomes. The study lays the groundwork for neoadjuvant immunotherapy in mesot . . .